Protagonist Therapeutics, Inc. (PTGX)
PTGX price $139.52 +1.44 +1.04%
- Ticker
- PTGX
- Price
- $139.52
- Change
- +1.44 +1.04%
- Market cap
- $9.03B
- P/E
- 113.36
- Forward P/E
- 30.35
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 55
Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's pipeline features rusfertide (PTG-300), an injectable hepcidin mimetic currently undergoing Phase II clinical trials for the management of…